Asciminib: overcoming TKI resistance and reducing toxicity in CML VJHemOnc – Video Journal of Hematology & HemOnc 3:26 5 years ago 3 676 Скачать Далее
Targeting TKI-resistant CML with LY3009120 and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 2:40 2 years ago 362 Скачать Далее
Ongoing studies in CML: investigating asciminib toxicity and improving TFR rates VJHemOnc – Video Journal of Hematology & HemOnc 1:24 1 year ago 258 Скачать Далее
Asciminib has the potential to succeed where other TKIs have failed in CML VJHemOnc – Video Journal of Hematology & HemOnc 0:58 5 years ago 505 Скачать Далее
Fourth generation TKIs for CML: asciminib VJHemOnc – Video Journal of Hematology & HemOnc 1:32 5 years ago 1 155 Скачать Далее
Understanding the cause of TKI resistance to improve management strategies in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:45 1 year ago 161 Скачать Далее
Managing drug resistance in CP-CML with ponatinib and asciminib VJHemOnc – Video Journal of Hematology & HemOnc 1:08 7 months ago 94 Скачать Далее
Asciminib plus traditonal TKIs for chronic phase CML VJHemOnc – Video Journal of Hematology & HemOnc 3:08 5 years ago 615 Скачать Далее
Dr. Michael Mauro on Toxicities of TKI Usage in CML Patients Targeted Oncology 1:07 8 years ago 381 Скачать Далее
Addressing the issue of resistance to TKIs in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:11 1 year ago 61 Скачать Далее
Downregulation of MS4A3 promotes TKI resistance in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:42 2 years ago 47 Скачать Далее
Tolerability of bosutinib vs asciminib in heavily pre-treated patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 1 year ago 153 Скачать Далее
Phase I study of asciminib in patients with CP-CML carrying the T315I mutation VJHemOnc – Video Journal of Hematology & HemOnc 1:03 1 year ago 390 Скачать Далее
Management of chronic myeloid leukemia: an update International Academy for Clinical Hematology IACH 43:20 1 year ago 1 309 Скачать Далее
Andreas Hochhaus: Asciminib vs. Bosutinib in Chronic Myeloid Leukemia American Society of Hematology 5:37 3 years ago 1 199 Скачать Далее
Asciminib versus other TKIs in the frontline treatment of CML: the ASC4FIRST study VJHemOnc – Video Journal of Hematology & HemOnc 1:46 1 month ago 106 Скачать Далее
The use of asciminib versus ponatinib for multiresistant CML VJHemOnc – Video Journal of Hematology & HemOnc 2:51 1 year ago 1 121 Скачать Далее
